Valid BREAST-Q questionnaire for analysis of the outcomes in aesthetic breast surgery

Korableva N.P.; Zholtikov V.V.; Ismagilov A.Kh.; Dokhov M.A.; Lebedeva Yu.V.

doi:https://doi.org/10.17116/plast.hirurgia202004117

Korableva N.P.

Saint Petersburg State Pediatric Medical University

Zholtikov V.V.

Atribeaute Clinic

Ismagilov A.Kh.

Republican Clinical Oncology Dispensary

Dokhov M.A.

Saint Petersburg State Pediatric Medical University

Lebedeva Yu.V.

Saint Petersburg State Pediatric Medical University

ORCID: 0000-0001-9116-9589

Valid BREAST-Q questionnaire for analysis of the outcomes in aesthetic breast surgery

Authors:

Korableva N.P., Zholtikov V.V., Ismagilov A.Kh., Dokhov M.A., Lebedeva Yu.V.

More about the authors

Journal: Plastic Surgery and Aesthetic Medicine. 2020;(4): 17‑22

DOI: 10.17116/plast.hirurgia202004117

Read: 4027 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Korableva NP, Zholtikov VV, Ismagilov AKh, Dokhov MA, Lebedeva YuV. Valid BREAST-Q questionnaire for analysis of the outcomes in aesthetic breast surgery. Plastic Surgery and Aesthetic Medicine. 2020;(4):17‑22. (In Russ.)
https://doi.org/10.17116/plast.hirurgia202004117

Подписка 2026 Пластическая хирургия и эстетическая медицина (Plastic Surgery and Aesthetic Medicine)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To perform the linguistic validation of the BREAST-Q Russian Version 2.0 questionnaire as a method for assessing the results of aesthetic mammoplasty.

MATERIAL AND METHODS

Validation consisted of 5 stages and subsequent statistical analysis of the data. Linguistic validation was performed in two modules for specific operations (breast augmentation and reduction/mastopexy). The validated questionnaires were tested in 100 patients.

RESULTS

The linguistic validation of two modules of aesthetic surgery (breast augmentation and reduction/mastopexy) was carried out. Each of these modules has preoperative and postoperative scales corresponding to the Rush criterion and traditional psychometric criteria: Cronbach’s alpha coefficient 0.81—0.96; reproducibility of test-retesting — 0.7—0.9.

CONCLUSION

Currently, the BREAST-Q questionnaire is the only tool for evaluating the results of aesthetic breast surgery in accordance with international and federal standards. BREAST-Q Version 2.0 questionnaire ensures the important data for improvement in breast augmentation and reduction/mastopexy from the perspective of both surgeons and patients due to its unique psychometric properties.

Keywords:

aesthetic breast surgery

breast augmentation

breast reduction

quality of life questionnaire

augmentation mammoplasty

results

patient satisfaction

quality of life

BREAST-Q

breast

Authors:

Korableva N.P.

Saint Petersburg State Pediatric Medical University

Zholtikov V.V.

Atribeaute Clinic

Ismagilov A.Kh.

Republican Clinical Oncology Dispensary

Dokhov M.A.

Saint Petersburg State Pediatric Medical University

Lebedeva Yu.V.

Saint Petersburg State Pediatric Medical University

ORCID: 0000-0001-9116-9589

Received:

16.09.2020

Accepted:

10.10.2020

Close metadata

References:

Svanadze S, Skvirskaya GP. The emergence of aesthetic medicine market in Russia. Sečenovskij vestnik. 2016;(4):9-12. (In Russ.).
Svanadze SN, Kutakova YuYu. The sociological evaluation of satisfaction of patients with quality of medical services related to mammoplastics. Sociology of medicine. 2016;2:110-113. (In Russ.). https://doi.org/10.1016/1728-2810-2016-15-2-110-113
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patientreported outcome mea sure for breast surgery: The BREAST-Q. Plast Reconstr Surg. 2009;124:345-353.
Pusic AL, Reavey PL, Klassen AF, Scott A, McCarthy C, Cano S. Measuring patient outcomes after breast augmentation: Introducing the BREAST-Q: Augmentation Module. Clin Plast Surg. 2009;36(1):23-32.
Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P; ISPOR Task Force for Translation and Cultural. Adaptation Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8:94-104. https://doi.org/10.1111/j.1524-4733.2005.04054.x
World Health Organization. Process of translation and adaptation of instruments. Geneva: WHO; 2016. Accessed February 12, 2016. https://www.who.int/substance_abuse/research_tools/translation/en/
Kryuk NV. Psychometric calibration and standardization of the five-factor personality inventory on the basis of the rasch model. Journal of the Grodno State Medical University. 2013;4:101-103. (In Russ.).
Ismagilov AKh, Yagdjyan GV, Vanesyan AS. Algorithm of cross-cultural adaptation of the BREAST-Q questionnaire. Oncology bulletin of the Volga region. 2013;3:49-52. (In Russ.).
Saiga M, Taira N, Kimata Y, Watanabe S, Mukai Y, Shimozuma K, Mizoo T, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H. Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgery. Breast Cancer. 2017;24(2):288-298. https://doi.org/10.1007/s12282-016-0703-6
Acquadro BC, Conway K, Girourdet C. Linguistic validation manual for patient-reported outcomes (PRO) instruments. Qual Life Res. 2005;14: 1791-1792.
Mundy LR, Homa K, Klassen AF, Pusic AL, Kerrigan CL. Breast cancer and reconstruction: normative data for interpreting the BREAST-Q. Plast Recon Surg. 2017;139(5):1046-1055. https://doi.org/10.1097/PRS.0000000000003241
Mundy LR, Homa K, Klassen AF, Pusic AL, Kerrigan CL. Normative data for interpreting the BREAST-Q augmentation module. Plast Reconstr Surg. 2017;139(4):846-853. https://doi.org/10.1097/PRS.0000000000003186
Mundy LR, Homa K, Klassen AF, Pusic AL, Kerrigan CL. Understanding the Health Burden of Macromastia: Normative Data for the BREAST-Q Reduction Module. Plast Reconstr Surg. 2017;139(4):846e-853e. https://doi.org/10.1097/PRS.0000000000003171